发明名称 METHODS FOR THE USE OF SPERMIDINE/SPERMINE N1-ACETYLTRANSFERASE AS A PROGNOSTIC INDICATOR AND/OR TUMOR RESPONSE MARKER
摘要 Disclosed is a method that relates to the measurement of determinants related to the in-vivo induction of spermidine/ spermine Nl-acetyltransferase (SSAT), subsequent to treatment with polyamine analogs that induce SSAT such as bis-ethyl spermine analogs, in tumor types responsive to this class of analogs. The method comprises the measurement of one or more SSAT-specific determinants that include SSAT enzyme activity, SSAT enzyme protein, and SSAT m-RNA transcripts. Alternatively, other determinants related to the SSAT induction may be measured. Such determinants include SSAT co-factor acetylCoenzyme A, and SSAT products Nl-acetylspermidineand Nl-acetylspermine. Measurements of these determinants may be useful as prognostic indicia and tumor response markers to evaluate the clinical effectiveness of anticancer agents comprising polyamine analogs, such as bis-ethyl spermine analogs, that induce SSAT activity.
申请公布号 CA2094341(A1) 申请公布日期 1993.10.29
申请号 CA19932094341 申请日期 1993.04.19
申请人 HEALTH RESEARCH INC. 发明人 PORTER, CARL W.
分类号 C12Q1/48;A61K31/13;G01N33/50;G01N33/574;(IPC1-7):C12Q1/68;G01N33/573 主分类号 C12Q1/48
代理机构 代理人
主权项
地址